XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 286,045 $ 473,244
Marketable securities 1,492,352 1,139,599
Accounts receivable, net of allowances of $1,164 and $979 at March 31, 2023 and December 31, 2022, respectively 516,106 440,896
Inventory 150,563 149,708
Prepaid expenses and other assets 67,567 60,824
Total current assets 2,512,633 2,264,271
Property and equipment, net 133,268 111,367
Operating lease, right of use asset, net 21,647 21,379
Intangible assets, net 92,756 99,541
Goodwill 213,882 213,559
Other assets 184,138 169,291
Deferred tax assets, net 222,529 204,872
Total assets 3,380,853 3,084,280
Current liabilities:    
Accounts payable 106,154 125,085
Accrued liabilities 396,688 295,939
Deferred revenues, current 99,819 90,747
Warranty obligations, current 34,513 35,556
Debt, current 92,115 90,892
Total current liabilities 729,289 638,219
Long-term liabilities:    
Deferred revenues, non-current 322,487 281,613
Warranty obligations, non-current 111,521 95,890
Other liabilities 47,187 43,520
Debt, non-current 1,200,276 1,199,465
Total liabilities 2,410,760 2,258,707
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Common stock, $0.00001 par value, 300,000 shares authorized; and 137,002 shares and 136,441 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively 1 1
Additional paid-in capital 812,618 819,119
Accumulated equity 164,208 17,335
Accumulated other comprehensive loss (6,734) (10,882)
Total stockholders’ equity 970,093 825,573
Total liabilities and stockholders’ equity $ 3,380,853 $ 3,084,280
Common stock, shares authorized (in shares) 300,000,000 300,000,000